{"id":407717,"date":"2025-10-21T00:30:00","date_gmt":"2025-10-20T22:30:00","guid":{"rendered":"https:\/\/medizinonline.com\/cgrp-targeted-migraine-therapies-for-vascular-risk-patients\/"},"modified":"2025-10-20T21:55:59","modified_gmt":"2025-10-20T19:55:59","slug":"cgrp-targeted-migraine-therapies-for-vascular-risk-patients","status":"publish","type":"post","link":"https:\/\/medizinonline.com\/en\/cgrp-targeted-migraine-therapies-for-vascular-risk-patients\/","title":{"rendered":"CGRP-targeted migraine therapies for vascular risk patients"},"content":{"rendered":"\n

Migraine is one of the most common neurological disorders and affects millions of people worldwide. With the development of CGRP-targeted therapies – monoclonal antibodies and Gepanten – the treatment of this widespread disease has experienced a turning point in recent years. These substances are highly effective, have a favorable side-effect profile and are clearly pathophysiologically targeted. However, one patient group remains cautious: people with vascular risk factors or who have already suffered cerebrovascular disease. Particularly in this group, which was often excluded from clinical trials, crucial questions arise: How safe is blockade of the CGRP system really? What data is available and where are there still gaps? <\/strong><\/p>\n\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"excerpt":{"rendered":"

Migraine is one of the most common neurological disorders and affects millions of people worldwide. With the development of CGRP-targeted therapies – monoclonal antibodies and Gepanten – the treatment of……... <\/p>\n

Dieser Inhalt ist nur f\u00fcr Benutzer der Gruppe: Medizinische Fachperson zug\u00e4nglich
Jetzt beitreten<\/a><\/div>
Already a member? Log in here<\/a><\/div><\/div><\/div>","protected":false},"author":7,"featured_media":407719,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"pmpro_default_level":"","cat_1_feature_home_top":false,"cat_2_editor_pick":false,"csco_eyebrow_text":"Migraine and vascular regulation","footnotes":""},"category":[11508,11363,11548,11503],"tags":[19765,13856],"powerkit_post_featured":[],"class_list":["post-407717","post","type-post","status-publish","format-standard","has-post-thumbnail","category-education","category-neurology","category-rx-en","category-studies","tag-cgrp-en","tag-migraine","pmpro-level-required","pmpro-level-1","pmpro-no-access"],"acf":[],"publishpress_future_action":{"enabled":false,"date":"2026-04-14 15:36:42","action":"change-status","newStatus":"draft","terms":[],"taxonomy":"category","extraData":[]},"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":407711,"slug":"traitements-de-la-migraine-cibles-par-le-cgrp-chez-les-patients-a-risque-vasculaire","post_title":"Traitements de la migraine cibl\u00e9s par le CGRP chez les patients \u00e0 risque vasculaire","href":"https:\/\/medizinonline.com\/fr\/traitements-de-la-migraine-cibles-par-le-cgrp-chez-les-patients-a-risque-vasculaire\/"},"it_IT":{"locale":"it_IT","id":407705,"slug":"terapie-dellemicrania-mirate-al-cgrp-per-i-pazienti-a-rischio-vascolare","post_title":"Terapie dell'emicrania mirate al CGRP per i pazienti a rischio vascolare","href":"https:\/\/medizinonline.com\/it\/terapie-dellemicrania-mirate-al-cgrp-per-i-pazienti-a-rischio-vascolare\/"},"pt_PT":{"locale":"pt_PT","id":407699,"slug":"terapeuticas-para-a-enxaqueca-direcionadas-para-o-cgrp-em-doentes-com-risco-vascular","post_title":"Terap\u00eauticas para a enxaqueca direcionadas para o CGRP em doentes com risco vascular","href":"https:\/\/medizinonline.com\/pt-pt\/terapeuticas-para-a-enxaqueca-direcionadas-para-o-cgrp-em-doentes-com-risco-vascular\/"},"es_ES":{"locale":"es_ES","id":407694,"slug":"terapias-contra-la-migrana-dirigidas-al-cgrp-para-pacientes-con-riesgo-vascular","post_title":"Terapias contra la migra\u00f1a dirigidas al CGRP para pacientes con riesgo vascular","href":"https:\/\/medizinonline.com\/es\/terapias-contra-la-migrana-dirigidas-al-cgrp-para-pacientes-con-riesgo-vascular\/"}},"_links":{"self":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/407717","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/comments?post=407717"}],"version-history":[{"count":1,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/407717\/revisions"}],"predecessor-version":[{"id":407721,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/posts\/407717\/revisions\/407721"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media\/407719"}],"wp:attachment":[{"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/media?parent=407717"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/category?post=407717"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/tags?post=407717"},{"taxonomy":"powerkit_post_featured","embeddable":true,"href":"https:\/\/medizinonline.com\/en\/wp-json\/wp\/v2\/powerkit_post_featured?post=407717"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}